Changchun BCHT Biotechnology Co.
Changchun BCHT Biotechnology Co.
Explore linked clinical trials.11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine | Herpse Zoster | Not yet recruiting | Early phase 1 | 2026-08-07 | NCT07753265 | |
| A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) | DNA Virus Infections, Herpesviridae infectious disease, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, herpes simplex infectious disease, skin disorder, skin disorder caused by infection, viral infectious disease | Enrolling by invitation | Phase 1 | 2026-06-08 | NCT07633197 | |
| A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza Vaccine | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Enrolling by invitation | Phase 4 | 2026-04-22 | NCT07545564 | |
| A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell) | Rabies Prevention | Enrolling by invitation | Phase 3 | 2026-03-30 | NCT07500207 | |
| A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus | Not yet recruiting | Phase 1 | 2026-03-25 | NCT07492303 | |
| A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant) | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Not yet recruiting | Phase 1 | 2026-01-16 | NCT07349017 | |
| A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell) | RabiesPrevention | Enrolling by invitation | Phase 1 | 2026-01-14 | NCT07338786 | |
| A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination | DNA Virus Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Herpesviridae infectious disease, Infections, Male Urogenital Diseases, Urogenital Diseases, female reproductive system disorder, genital herpes, herpes simplex infectious disease, infectious disease, male reproductive system disorder, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Enrolling by invitation | Phase 1 | 2026-01-09 | NCT07330440 | |
| Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination | Prevention of Influenza | Not yet recruiting | Phase 3 | 2025-08-21 | NCT07133802 | |
| Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial | Prevent Diphtheria; Prevent Tetanus; Prevent Whooping Cough | Recruiting | Phase 3 | 2025-08-08 | NCT07112144 | |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and Older | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Not yet recruiting | Phase 4 | 2025-05-08 | NCT06961721 |